TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Polyphyllin I, Palbociclib
Phytochemical Name Polyphyllin I (PubChem CID: 72960700 )
Anticancer drug Name Palbociclib (PubChem CID: 5330286 )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Reversing Drug Resistance
Hide/Show
Combination Pair ID: 58
Pair Name Polyphyllin I, Palbociclib
Disease Info [ICD-11: 2C25] Lung cancer Investigative
Biological Phenomena Induction-->Apoptosis
Gene Regulation Up-regulation Cleavage CASP3 hsa836
Down-regulation Expression CCNE1 hsa898
Down-regulation Phosphorylation CDK2 hsa1017
Down-regulation Phosphorylation CDK4 hsa1019
Down-regulation Phosphorylation CDK6 hsa1021
Up-regulation Expression CDKN1A hsa1026
Down-regulation Phosphorylation RB1 hsa5925
In Vitro Model A-549 Lung adenocarcinoma Homo sapiens (Human) CVCL_0023
NCI-H460 Lung large cell carcinoma Homo sapiens (Human) CVCL_0459
In Vivo Model A549 cells (3×10⁶) in 0.2 mL medium were injected subcutaneously into the right flank of each nude mice.
Result We first time demonstrated PPI can disturb CDK2 function through upregulation of p21. The PPI effect on CDK2 provides a choice for a chemotherapeutic strategy for the elimination of NSCLC. Our study highlighted the clinical significance of simultaneously blocking of CDK2 and CDK4/6 for NSCLC treatment.
03. Reference
No. Title Href
1 Polyphyllin I, a lethal partner of Palbociclib, suppresses non-small cell lung cancer through activation of p21/CDK2/Rb pathway in vitro and in vivo. Cell Cycle. 2021 Dec;20(23):2494-2506. doi: 10.1080/15384101.2021.1991121. Click
It has been 26401 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP